These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24378999)

  • 21. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.
    Tocci G; Palano F; Pagannone E; Chin D; Ferrucci A; Volpe M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):115-23. PubMed ID: 19210207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide.
    Guerrero P; Fuchs FD; Moreira LM; Martins VM; Bertoluci C; Fuchs SC; Gus M
    Clin Exp Hypertens; 2008 Oct; 30(7):553-64. PubMed ID: 18855259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of fixed-dose combinations in the management of hypertension: focus on lercanidipine-enalapril.
    Chatzikyrkou C; Haller H; Menne J
    Expert Opin Pharmacother; 2009 Aug; 10(11):1833-40. PubMed ID: 19527194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trial.
    Mancia G; Coca A; Chazova I; Girerd X; Haller H; Pauletto P; Pupek-Musialik D; Svyshchenko Y;
    J Hypertens; 2014 Aug; 32(8):1700-7; discussion 1707. PubMed ID: 24906174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
    Burnier M; Pruijm M; Wuerzner G
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of arteril hypertension in patients with chronic kidney disease: a fixed combination of lercanidipine and enalapril].
    Minushkina LO
    Kardiologiia; 2013; 53(12):64-9. PubMed ID: 24800484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of antihypertensive treatment with lercanidipine on endothelial progenitor cells and inflammation in patients with mild to moderate essential hypertension.
    De Ciuceis C; Rossini C; Tincani A; Airò P; Scarsi M; Agabiti-Rosei C; Ruggeri G; Caimi L; Ricotta D; Agabiti-Rosei E; Rizzoni D
    Blood Press; 2016 Dec; 25(6):337-343. PubMed ID: 27195656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.
    Omboni S; Malacco E; Napoli C; Modesti PA; Manolis A; Parati G; Agabiti-Rosei E; Borghi C
    Adv Ther; 2017 Apr; 34(4):784-798. PubMed ID: 28260186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of a lercanidipine/enalapril fixed-dose combination in hypertensive patients in Portugal.
    Maldonado J; Pereira T; Tavares A
    Drugs R D; 2014 Jun; 14(2):147-54. PubMed ID: 24831818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of efficacy and safety between benidipine and hydrochlorothiazide in fosinopril-treated hypertensive patients with chronic kidney disease: protocol for a randomised controlled trial.
    Xue C; Zhou C; Yang B; Lv J; Dai B; Yu S; Wang Y; Zhao G; Mei C
    BMJ Open; 2017 Feb; 7(2):e013672. PubMed ID: 28237959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the Efficacy and Safety of the Lercanidipine/Valsartan Combination in Korean Patients With Essential Hypertension Not Adequately Controlled With Lercanidipine Monotherapy: A Randomized, Multicenter, Parallel Design, Phase III Clinical Trial.
    Na SH; Lee HY; Hong Baek S; Jeon HK; Kang JH; Kim YN; Park CG; Ryu JK; Rhee MY; Kim MH; Hong TJ; Choi DJ; Cho SW; Cha DH; Jeon ES; Kim JJ; Shin JH; Park SH; Lee SH; John SH; Shin ES; Kim NH; Lee SY; Kwan J; Jeong MH; Kim SW; Jeong JO; Kim DW; Lee NH; Park WJ; Ahn JC; Won KH; Uk Lee S; Cho JH; Kim SK; Ahn T; Hong S; Yoo SY; Kim SY; Kim BS; Juhn JH; Kim SY; Lee YJ; Oh BH
    Clin Ther; 2015 Aug; 37(8):1726-39. PubMed ID: 26164786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of lercanidipine/enalapril fixed combination in Lebanon: a prospective observational study.
    Arnaout S;
    Curr Med Res Opin; 2015 Jan; 31(1):187-90. PubMed ID: 25424779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enalapril/lercanidipine combination on markers of cardiovascular risk: a randomized study.
    Derosa G; Bonaventura A; Romano D; Bianchi L; Fogari E; D'Angelo A; Maffioli P
    J Am Soc Hypertens; 2014 Jun; 8(6):422-8. PubMed ID: 24836352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative efficacy of fixed dose combinations of enalapril with hydrochlorothiazide and captopril with hydrochlorothiazide in patients with high risk hypertension].
    Nedogoda SV
    Kardiologiia; 2005; 45(12):40-1. PubMed ID: 16353046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphism of the methylenetetrahydrofolate reductase gene C677T and its influence on the antihypertensive and vascular protective effects of short-term lercanidipine treatment.
    Xu H; Zheng H; Shen Y; Huang J; Luo M
    Gene; 2012 Jun; 500(2):207-10. PubMed ID: 22503897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fixed-dose lercanidipine and enalapril in field practice: a meta-analysis.
    Rizzoni D
    Curr Med Res Opin; 2016 Oct; 32(sup2):13-15. PubMed ID: 27779457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.
    Levi-Marpillat N; Macquin-Mavier I; Tropeano AI; Parati G; Maison P
    Hypertens Res; 2014 Jun; 37(6):585-90. PubMed ID: 24671016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.